Can LASSBio 596 and dexamethasone treat acute lung and liver inflammation induced by microcystin-LR?

Toxicon

Volumn 56, Issue 4, 2010, Pages 604-612

  Carvalho, Giovanna M C ^a   Oliveira, Vinícius R ^a   Soares, Raquel M ^a   Azevedo, Sandra M F O ^a   Lima, Lidia M ^a   Barreiro, Eliezer J ^a   Valença, Samuel S ^a   Saldiva, Paulo H N ^b   Faffe, Débora S ^a   Zin, Walter A ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute lung inflammation; Anti inflammatory; Corticosteroid; Cyanobacteria; Lung mechanics; Microcystin LR

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; L 596; MICROCYSTIN LR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; HEPATITIS; HISTOPATHOLOGY; INFLAMMATORY CELL; LIVER PROTECTION; LUNG COLLAPSE; LUNG MECHANICS; LUNG VASCULAR RESISTANCE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TOXIN ANALYSIS;

CYANOBACTERIA; MUS;

EID: 77954959710     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.06.005     Document Type: Article

References (44)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Andrinolo D., Sedan D., Telese L., Aura C., Masera S., Giannuzzi L., Marra C.A., Alaniz M.J.T. Hepatic recovery after damage produced by sub-chronic intoxication with the cyanotoxin microcystin LR. Toxicon 2008, 51:457-467.
3. Azevedo S.M.F.O., Carmichael W.W., Jochimsen E.M., Rinehart K.L., Lau S., Shaw G.R., Eaglesham G.K. Human intoxication by microcystins during renal dialysis treatment in Caruaru - Brazil. Toxicology 2002, 181:441-446.
4. Bannister J.V., Calabrese L. Assays for superoxide dismutase. Methods Biochem. Anal. 1987, 32:279-312.
5. Barreto V., Lira V., Figueiredo J., Fittipaldi H., Juca N., Gayotto L.C., Raposso F., Barbosa J., Holmes C., Cardo C., Azevedo S.M.F.O., Carmichael W. Caruaru Syndrome-a previously undescribed form of acute toxic liver disease in humans caused by microcystin-LR with high lethality rate. Hepatology 1996, 24(4 Pt 2):244. (Abstract Am. Assoc. for the Study of Liver Diseases).
6. Bates J.H.T., Rossi A., Milic-Emili J. Analysis of the behavior of the respiratory system with constant inspiration flow. J. Appl. Physiol. 1985, 58:1840-1848.
7. Bates J.H.T., Ludwig M.S., Sly P.D., Brown K., Martin J.G., Fredberg J.J. Interrupter resistance elucidated by alveolar pressure measurement in open-chest normal dogs. J. Appl. Physiol. 1988, 65:408-414.
8. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
9. Brooks W.P., Codd G.A. Distribution of Microcystis aeruginosa peptide toxin and interactions with hepatic microsomes in mice. Pharmacol. Toxicol. 1987, 60:187-191.
10. Campos H.S., Xisto D.G., Oliveira M.B., Teixeira I., Negri E.M., Mauad T., Carnielli D., Lima L.M., Barreiro E.J., Faffe D.S., Zin W.A., Lapa e Silva J.R., Rocco P.R. Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma. Braz. J. Med. Biol. Res. 2006, 39:283-287.
11. Carmichael W.W. The toxins of cyanobacteria. Sci. Am. 1994, 270:78-86.
12. Chorus I., Bartram J. Toxic Cyanobacteria in Water - A Guide to Their Public Health Consequences, Monitoring and Management 1999, E & FN Spon, London.
13. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990, 186:421-431.
14. Dawson R.M. The toxicology of microcystins. Toxicon 1998, 36:953-962.
15. Feurstein D., Holst K., Fischer A., Dietrich D.R. Oatp-associated uptake and toxicity of microcystin in primary murine whole brain cells. Toxicol. Appl. Pharmacol. 2009, 234:247-255.
16. Fugiki H. Is the inhibition of protein phosphatase 1 and 2A activities a general mechanism of tumor promotion in human cancer development?. Mol. Carcinog. 1992, 5:91-94.
17. Funari E., Testai E. Human health risk assessment related to cyanotoxins exposure. Crit. Rev. Toxicol. 2008, 38:97-125.
18. Gundersen H.J.G., Bendtsen T.F., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J.R., Pakkenberg B., Sorensen F.B., Vesterby A., West M.J. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Acta Pathol. Microbiol. Immunol. Scand. 1988, 96:379-394.
19. Hooser S.B., Beasley V.R., Lovell R.A., Carmichael W.W., Haschek W.M. Toxicity of microcystin-LR, a cyclic heptapeptide hapatotoxin from Microcystis aeruginosa, to rats and mice. Vet. Pathol. 1989, 26:246-252.
20. Ito E., Kondo F., Harada K.-I. First report on the distribution of orally administered microcystin-LR in mouse tissue using an immunostaining method. Toxicon 2000, 38:37-48.
21. Ito E., Kondo F., Harada K.-I. Intratracheal administration of microcystin-LR and its distribution. Toxicon 2001, 39:265-271.
22. Kujbida P., Hatanaka E., Campa A., Curi R., Farsky S.H.P., Pinto E. Analysis of chemokines and reactive oxygen species formation by rat and human neutrophils induced by microcystin-LA, -YR and -LR. Toxicon 2008, 51:1274-1280.
23. Lima L.M., Castro P., Machado A.L., Fraga C.A., Lugnier C., de Moraes V.L., Barreiro E.J. Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues. Bioorg. Med. Chem. 2002, 10:3067-3073.
24. Miotla J.M., Teixeira M.M., Hellewell P.G. Supression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4. Am. J. Respir. Cell. Mol. Biol. 1998, 18:411-420.
25. Moreno I.M., Pichardo S., Jos A., Gomez-Amores L., Mate A., Vazquez C.M., Camean A.M. Antioxidant enzyme activity and lipid peroxidation in liver and kidney of rats exposed to microcystin-LR administered intraperitoneally. Toxicon 2005, 45:395-402.
26. Mortola J.P., Noworaj J.A. Two-sidearm tracheal cannula for respiratory airflow measurements in small animals. J. Appl. Physiol. 1983, 55:250-253.
27. Nakano Y., Shirai M., Mori N., Nakano M. Neutralization of microcystin shock in mice by tumor necrosis factor alpha antiserum. Appl. Environ. Microbiol. 1991, 57:327-330.
28. Naseen S.M., Hines H.B., Creasia D.A. Effect of toxins on arachidonic acid metabolism in rat cultured pulmonary alveolar macrophages. Biochem. Int. 1989, 19:583-592.
29. 2 and cyclooxygenase in renal toxicity induced by microcystin-LR. Toxicon 2001, 39:721-724.
30. Nobre A.C.L., Martins A.M., Hayt A., Benevides C., Lima A.A., Fonteneles M.C., Monteiro H.S. Renal effects of supernatant from rat peritoneal macrophages activated by microcystin-LR: role protein mediators. Toxicon 2003, 41:377-381.
31. Picanço M.R., Soares R.M., Cagido V.R., Azevedo S.M.F.O., Rocco P.R.M., Zin W.A. Toxicity of a cyanobacterial extract containing microcystins to mouse lungs. Braz. J. Med. Biol. Res. 2004, 37:1225-1229.
32. Robinson N.A., Miura G.A., Matson C.F., Dinterman R.E., Pace J.G. Characterization of chemically tritiated microcystin-LR and its distribution in mice. Toxicon 1989, 27:1035-1042.
33. Robinson N.A., Pace J.G., Matson C.F., Miura G.A., Lawrence W.B. Tissue distribution, excretion and hepatic biotransformation of microcystin-LR in mice. J. Pharmacol. Exp. Ther. 1991, 256:176-182.
34. Rocco P.R., Momesso D.P., Figueira R.C., Ferreira H.C., Cadete R.A., Légora-Machado A., Koatz V.L., Lima L.M., Barreiro E.J., Zin W.A. Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury. Eur. Respir. J. 2003, 22:20-27.
35. Rugstad H.E. Antiinflammatory and immunoregulatory effects of glucocorticoids: mode of action. Scand. J. Rheumatol. Suppl. 1988, 76:257-264.
36. Saldiva P.H., Zin W.A., Santos R.L., Eidelman D.H., Milic-Emili J. Alveolar pressure measurement in open-chest rats. J. Appl. Physiol. 1992, 72:302-306.
37. Soares R.M., Cagido V.R., Ferraro R.B., Meyer-Fernandes J.R., Rocco R.M., Zin W.A., Azevedo S.M.F.O. Effects of microcystin-LR on mouse lungs. Toxicon 2007, 50:330-338.
38. Suzuki K., Ota H., Sasagawa S., Sakatani T., Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal. Biochem. 1983, 132:345-352.
39. Tadesse A., Sandoval F., Shannon E.J. Stabilization of red blood cell membranes by thalidomide in vitro. Immunopharmacol. Immunotoxicol. 2004, 26:501-509.
40. Teixeira Mda G., Costa Mda C., Carvalho V.L.P., Pereira Mdos.S., Hage E. Gastroenteritis epidemic in the area of the Itaparica dam, Bahia, Brazil. Bull. Pan Am. Health Organ 1993, 27:244-253.
41. Turner C.R. Therapeutic intervention in a rat model of ARDS: IV. Phosphodiesterase IV inhibition. Circ. Shock 1993, 39:237-245.
42. Turner P.C., Gamme A.J., Hollinrake K., Codd G.A. Pneumonia associated with cyanobacteria. Br. Med. J. 1990, 300:1400-1414.
43. Wang Q., Xie P., Chen J., Liang G. Distribution of microcystin in various organs (heart, liver, intestine, gonad, brain, kidney and lung) of Wistar rat via intravenous injection. Toxicon 2008, 52:721-727.
44. Zafir A., Banu N. Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats. Stress 2009, 12:167-177.